COMMUNIQUÉS West-GlobeNewswire

Purespring announces publication of notable study highlighting an under recognised genetic driver of adult-onset FSGS, in particular in US and UK populations
29/04/2026
Population modelling study published in Kidney International Reports Analysis of over 1.2 million genomes from five international databases predicts a substantial, previously underdiagnosed adult NPHS2-FSGS population [...]
Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers
29/04/2026
LOVELAND, Colo., April 29, 2026 (GLOBE NEWSWIRE) -- Enlitic today announced the completion of its integration with Sectra, enabling Enlitic to support Sectra customers directly with its Ensight platform. The integration [...]
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
29/04/2026
Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to be conducted in IBS Dosing of first patient of the Phase 2b ‘RISE’ trial anticipated in [...]
AB Science annonce le succès d’un placement prive de 3,2 millions d’euros
29/04/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE DE 3,2 MILLIONS D’EUROS Paris, 29 avril 2026, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce aujourd' [...]
Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery
29/04/2026
Funding will support commercial deployment, clinical adoption and further development and enhancement of the Hyperspectral Intelligence® platform for AI-assisted surgery Angelini Ventures Managing Director Tanja Dowe [...]
Phonak Virto ™ R Infinio Earns 2026 Red Dot Award for Product Design
29/04/2026
Recognition highlights precision-crafted customization and next-generation performance in a compact, in-the-ear hearing solution STÄFA, Switzerland, April 29, 2026 (GLOBE NEWSWIRE) -- Phonak, a global leader in [...]
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
29/04/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel [...]
AB Science announces the successful completion of a EUR 3.2 million private placement
29/04/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 3.2 MILLION PRIVATE PLACEMENT Paris, April 29, 2026, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces [...]
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
29/04/2026
MENLO PARK, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (Nasdaq: ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and [...]
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
29/04/2026
BEIJING, April 28, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
29/04/2026
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial [...]
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
29/04/2026
Greenville, South Carolina, April 28, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that Felix Mirando has resigned as a member of the Company’s Board of Directors for [...]
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
28/04/2026
ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company [...]
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SAN DIEGO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, [...]
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
28/04/2026
Mechelen, Belgium; April 28, 2026, 22:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the Company’s Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) held [...]
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
28/04/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2026 le 12 Mai 2026
28/04/2026
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2026 le 12 Mai 2026 Mont-Saint-Guibert, Belgique – 28 avril 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « [...]
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
28/04/2026
CARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the [...]

Pages